Cargando…
Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones
Fluoroquinolones are associated with an increased risk of Clostridioides difficile infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this study was to evaluate receipt of probiotics on develop...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396168/ https://www.ncbi.nlm.nih.gov/pubmed/34449745 http://dx.doi.org/10.3390/pharmacy9030141 |
_version_ | 1783744310379806720 |
---|---|
author | Sheffield, Mary E. Jones, Bruce M. Terrell, Blake Wagner, Jamie L. Bland, Christopher M. |
author_facet | Sheffield, Mary E. Jones, Bruce M. Terrell, Blake Wagner, Jamie L. Bland, Christopher M. |
author_sort | Sheffield, Mary E. |
collection | PubMed |
description | Fluoroquinolones are associated with an increased risk of Clostridioides difficile infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this study was to evaluate receipt of probiotics on development of primary CDI among hospitalized patients receiving fluoroquinolones. A retrospective cohort was evaluated that consisted of two groups of 100 patients each, admitted August 2018 through August 2020 that received ≥3 days of definitive monotherapy with levofloxacin or ciprofloxacin within 72 h of admission. Primary outcome was incidence of CDI. Secondary outcomes included rates of C. difficile diagnostic stool testing, additional infectious diagnostic testing, and non-CDI related gastrointestinal side effects. Patients on fluoroquinolones who received probiotics had a non-statistically significantly lower incidence in overall cases of CDI compared to those who did not receive probiotics (0% vs. 3%, p = 0.246). Patients who received probiotics had statistically significantly fewer C. difficile diagnostic stool tests performed (4% vs. 16%, p = 0.005) and fewer additional infectious diagnostic testing performed (4% vs. 10%, p = 0.096), respectively. Further research is warranted to optimize and standardize probiotic prescribing in high-risk patients. |
format | Online Article Text |
id | pubmed-8396168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83961682021-08-28 Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones Sheffield, Mary E. Jones, Bruce M. Terrell, Blake Wagner, Jamie L. Bland, Christopher M. Pharmacy (Basel) Article Fluoroquinolones are associated with an increased risk of Clostridioides difficile infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this study was to evaluate receipt of probiotics on development of primary CDI among hospitalized patients receiving fluoroquinolones. A retrospective cohort was evaluated that consisted of two groups of 100 patients each, admitted August 2018 through August 2020 that received ≥3 days of definitive monotherapy with levofloxacin or ciprofloxacin within 72 h of admission. Primary outcome was incidence of CDI. Secondary outcomes included rates of C. difficile diagnostic stool testing, additional infectious diagnostic testing, and non-CDI related gastrointestinal side effects. Patients on fluoroquinolones who received probiotics had a non-statistically significantly lower incidence in overall cases of CDI compared to those who did not receive probiotics (0% vs. 3%, p = 0.246). Patients who received probiotics had statistically significantly fewer C. difficile diagnostic stool tests performed (4% vs. 16%, p = 0.005) and fewer additional infectious diagnostic testing performed (4% vs. 10%, p = 0.096), respectively. Further research is warranted to optimize and standardize probiotic prescribing in high-risk patients. MDPI 2021-08-18 /pmc/articles/PMC8396168/ /pubmed/34449745 http://dx.doi.org/10.3390/pharmacy9030141 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sheffield, Mary E. Jones, Bruce M. Terrell, Blake Wagner, Jamie L. Bland, Christopher M. Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title | Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title_full | Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title_fullStr | Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title_full_unstemmed | Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title_short | Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones |
title_sort | influence of probiotics on the development of clostridioides difficile infection in patients receiving fluoroquinolones |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396168/ https://www.ncbi.nlm.nih.gov/pubmed/34449745 http://dx.doi.org/10.3390/pharmacy9030141 |
work_keys_str_mv | AT sheffieldmarye influenceofprobioticsonthedevelopmentofclostridioidesdifficileinfectioninpatientsreceivingfluoroquinolones AT jonesbrucem influenceofprobioticsonthedevelopmentofclostridioidesdifficileinfectioninpatientsreceivingfluoroquinolones AT terrellblake influenceofprobioticsonthedevelopmentofclostridioidesdifficileinfectioninpatientsreceivingfluoroquinolones AT wagnerjamiel influenceofprobioticsonthedevelopmentofclostridioidesdifficileinfectioninpatientsreceivingfluoroquinolones AT blandchristopherm influenceofprobioticsonthedevelopmentofclostridioidesdifficileinfectioninpatientsreceivingfluoroquinolones |